drugset / Trial / NCT00192478
Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524
RandomizedParallel-groupOpen-labelTreatment
Summary
MEDI-524 given for up to 5 doses at 3 and 15 mg/kg to high-risk children appeared to be safe and well tolerated.
Timeline
- Start
- 2004-02
- Primary completion
- 2006-05
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Motavizumab | Monoclonal antibody | 3 mg/kg | Intramuscular |
| Comparator | Motavizumab | Monoclonal antibody | 15 mg/kg | Intramuscular |